EBV MicroRNA BART16 suppresses Type i IFN signaling

Journal of Immunology

Volumn 198, Issue 10, 2017, Pages 4062-4073

  Hooykaas, Marjolein J G ^a   Van Gent, Michiel ^a   Soppe, Jasper A ^a   Kruse, Elisabeth ^a   Boer, Ingrid G J ^a   Van Leenen, Dik ^a   Groot Koerkamp, Marian J A ^b   Holstege, Frank C P ^b   Ressing, Maaike E ^a,c   Wiertz, Emmanuel J H J ^a   Lebbink, Robert Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Department of Radiation Oncology   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; INTERFERON; MICRORNA; MICRORNA BART16; UNCLASSIFIED DRUG; VIRUS RNA;

3' UNTRANSLATED REGION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DOWN REGULATION; EMBRYO; EPSTEIN BARR VIRUS; GENE EXPRESSION; HUMAN; HUMAN CELL; LATENT VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; VIRUS IMMUNITY; VIRUS REPLICATION; CELL LINE; GENETICS; HOST PATHOGEN INTERACTION; IMMUNE EVASION; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM;

CELL LINE; CREB-BINDING PROTEIN; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; INTERFERON TYPE I; MICRORNAS; RNA, VIRAL; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 85019669533     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501605     Document Type: Article

References (84)

1. Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 140: 805-820.
2. Schoggins, J. W., and C. M. Rice. 2011. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1: 519-525.
3. Ivashkiv, L. B., and L. T. Donlin. 2014. Regulation of type I interferon responses. Nat. Rev. Immunol. 14: 36-49.
4. Dunmire, S. K., O. A. Odumade, J. L. Porter, J. Reyes-Genere, D. O. Schmeling, H. Bilgic, D. Fan, E. C. Baechler, H. H. Balfour, Jr., and K. A. Hogquist. 2014. Primary EBV infection induces an expression profile distinct from other viruses but similar to hemophagocytic syndromes. PLoS One 9: E85422.
5. Fiola, S., D. Gosselin, K. Takada, and J. Gosselin. 2010. TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells. J. Immunol. 185: 3620-3631.
6. Severa, M., E. Giacomini, V. Gafa, E. Anastasiadou, F. Rizzo, M. Corazzari, A. Romagnoli, P. Trivedi, G. M. Fimia, and E. M. Coccia. 2013. EBV stimulates TLR- and autophagy-dependent pathways and impairs maturation in plasmacytoid dendritic cells: Implications for viral immune escape. Eur. J. Immunol. 43: 147-158.
7. Quan, T. E., R. M. Roman, B. J. Rudenga, V. M. Holers, and J. E. Craft. 2010. Epstein-Barr virus promotes interferon-alpha production by plasmacytoid dendritic cells. Arthritis Rheum. 62: 1693-1701.
8. Iwakiri, D., L. Zhou, M. Samanta, M. Matsumoto, T. Ebihara, T. Seya, S. Imai, M. Fujieda, K. Kawa, and K. Takada. 2009. Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J. Exp. Med. 206: 2091-2099.
9. Lim, W. H., S. Kireta, G. R. Russ, and P. T. Coates. 2007. Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice. Blood 109: 1043-1050.
10. Sharp, N. A., J. R. Arrand, and M. J. Clemens. 1989. Epstein-Barr virus replication in interferon-treated cells. J. Gen. Virol. 70: 2521-2526.
11. Kure, S., K. Tada, J. Wada, and O. Yoshie. 1986. Inhibition of Epstein-Barr virus infection in vitro by recombinant human interferons alpha and gamma. Virus Res. 5: 377-390.
12. Bowie, A. G., and L. Unterholzner. 2008. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 8: 911-922.
13. Feng, P., A. Moses, and K. Früh. 2013. Evasion of adaptive and innate immune response mechanisms by g-herpesviruses. Curr. Opin. Virol. 3: 285-295.
14. Schulz, K. S., and K. L. Mossman. 2016. Viral evasion strategies in type I IFN signaling - a summary of recent developments. Front. Immunol. 7: 498.
15. Hahn, A. M., L. E. Huye, S. Ning, J. Webster-Cyriaque, and J. S. Pagano. 2005. Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1. J. Virol. 79: 10040-10052.
16. Bentz, G. L., R. Liu, A. M. Hahn, J. Shackelford, and J. S. Pagano. 2010. Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta. Virology 402: 121-128.
17. Wang, J. T., S. L. Doong, S. C. Teng, C. P. Lee, C. H. Tsai, and M. R. Chen. 2009. Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway. J. Virol. 83: 1856-1869.
18. Wu, L., E. Fossum, C. H. Joo, K. S. Inn, Y. C. Shin, E. Johannsen, L. M. Hutt- Fletcher, J. Hass, and J. U. Jung. 2009. Epstein-Barr virus LF2: An antagonist to type I interferon. J. Virol. 83: 1140-1146.
19. van Gent, M., S. G. Braem, A. de Jong, N. Delagic, J. G. Peeters, I. G. Boer, P. N. Moynagh, E. Kremmer, E. J. Wiertz, H. Ovaa, et al. 2014. Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling. PLoS Pathog. 10: E1003960.
20. Cohen, J. I., and K. Lekstrom. 1999. Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells. J. Virol. 73: 7627-7632.
21. van Gent, M., B. D. Griffin, E. G. Berkhoff, D. van Leeuwen, I. G. Boer, M. Buisson, F. C. Hartgers, W. P. Burmeister, E. J. Wiertz, and M. E. Ressing. 2011. EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection. J. Immunol. 186: 1694-1702.
22. Shah, K. M., S. E. Stewart, W. Wei, C. B. Woodman, J. D. O'Neil, C. W. Dawson, and L. S. Young. 2009. The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation. Oncogene 28: 3903-3914.
23. Kanda, K., T. Decker, P. Aman, M. Wahlström, A. von Gabain, and B. Kallin. 1992. The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3. Mol. Cell. Biol. 12: 4930-4936.
24. Nanbo, A., K. Inoue, K. Adachi-Takasawa, and K. Takada. 2002. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. EMBO J. 21: 954-965.
25. Kutok, J. L., and F. Wang. 2006. Spectrum of Epstein-Barr virus-associated diseases. Annu. Rev. Pathol. 1: 375-404.
26. Longnecker, R. M., E. Kieff, and J. I. Cohen. 2013. Epstein-Barr virus. In Field's Virology. D. M. Knipe, and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia, p. 1898-1959.
27. Bartel, D. P. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233.
28. Grundhoff, A., and C. S. Sullivan. 2011. Virus-encoded microRNAs. Virology 411: 325-343.
29. Pfeffer, S., M. Zavolan, F. A. Grässer, M. Chien, J. J. Russo, J. Ju, B. John, A. J. Enright, D. Marks, C. Sander, and T. Tuschl. 2004. Identification of virusencoded microRNAs. Science 304: 734-736.
30. Cullen, B. R. 2013. MicroRNAs as mediators of viral evasion of the immune system. Nat. Immunol. 14: 205-210.
31. Boss, I. W., and R. Renne. 2010. Viral miRNAs: Tools for immune evasion. Curr. Opin. Microbiol. 13: 540-545.
32. Xia, T., A. O'Hara, I. Araujo, J. Barreto, E. Carvalho, J. B. Sapucaia, J. C. Ramos, E. Luz, C. Pedroso, M. Manrique, et al. 2008. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res. 68: 1436-1442.
33. Kim, Y., S. Lee, S. Kim, D. Kim, J. H. Ahn, and K. Ahn. 2012. Human cytomegalovirus clinical strain-specific microRNA miR-UL148D targets the human chemokine RANTES during infection. PLoS Pathog. 8: E1002577.
34. Tagawa, T., M. Albanese, M. Bouvet, A. Moosmann, J. Mautner, V. Heissmeyer, C. Zielinski, D. Lutter, J. Hoser, M. Hastreiter, et al. 2016. Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J. Exp. Med. 213: 2065-2080.
35. Haneklaus, M., M. Gerlic, M. Kurowska-Stolarska, A. A. Rainey, D. Pich, I. B. McInnes, W. Hammerschmidt, L. A. O'Neill, and S. L. Masters. 2012. Cutting edge: MiR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1b production. J. Immunol. 189: 3795-3799.
36. Bauman, Y., D. Nachmani, A. Vitenshtein, P. Tsukerman, N. Drayman, N. Stern-Ginossar, D. Lankry, R. Gruda, and O. Mandelboim. 2011. An identical miRNA of the human JC and BK polyoma viruses targets the stressinduced ligand ULBP3 to escape immune elimination. Cell Host Microbe 9: 93-102.
37. Nachmani, D., N. Stern-Ginossar, R. Sarid, and O. Mandelboim. 2009. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5: 376-385.
38. Stern-Ginossar, N., C. Gur, M. Biton, E. Horwitz, M. Elboim, N. Stanietsky, M. Mandelboim, and O. Mandelboim. 2008. Human microRNAs regulate stressinduced immune responses mediated by the receptor NKG2D. Nat. Immunol. 9: 1065-1073.
39. Kim, S., S. Lee, J. Shin, Y. Kim, I. Evnouchidou, D. Kim, Y. K. Kim, Y. E. Kim, J. H. Ahn, S. R. Riddell, et al. 2011. Human cytomegalovirus microRNA miRUS4- 1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1. Nat. Immunol. 12: 984-991.
40. Albanese, M., T. Tagawa, M. Bouvet, L. Maliqi, D. Lutter, J. Hoser, M. Hastreiter, M. Hayes, B. Sugden, L. Martin, et al. 2016. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Proc. Natl. Acad. Sci. USA 113: E6467-E6475.
41. Abend, J. R., D. Ramalingam, P. Kieffer-Kwon, T. S. Uldrick, R. Yarchoan, and J. M. Ziegelbauer. 2012. Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin- 1R signaling cascade, to reduce inflammatory-cytokine expression. J. Virol. 86: 11663-11674.
42. Lei, X., Z. Bai, F. Ye, J. Xie, C. G. Kim, Y. Huang, and S. J. Gao. 2010. Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat. Cell Biol. 12: 193-199.
43. Liang, D., Y. Gao, X. Lin, Z. He, Q. Zhao, Q. Deng, and K. Lan. 2011. A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKϵ. Cell Res. 21: 793-806.
44. Motsch, N., J. Alles, J. Imig, J. Zhu, S. Barth, T. Reineke, M. Tinguely, S. Cogliatti, A. Dueck, G. Meister, et al. 2012. MicroRNA profiling of Epstein- Barr virus-associated NK/T-cell lymphomas by deep sequencing. PLoS One 7: E42193.
45. Amoroso, R., L. Fitzsimmons, W. A. Thomas, G. L. Kelly, M. Rowe, and A. I. Bell. 2011. Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation. J. Virol. 85: 996-1010.
46. Qiu, J., K. Cosmopoulos, M. Pegtel, E. Hopmans, P. Murray, J. Middeldorp, M. Shapiro, and D. A. Thorley-Lawson. 2011. A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog. 7: E1002193.
47. Barth, S., G. Meister, and F. A. Grässer. 2011. EBV-encoded miRNAs. Biochim. Biophys. Acta 1809: 631-640.
48. Klinke, O., R. Feederle, and H. J. Delecluse. 2014. Genetics of Epstein-Barr virus microRNAs. Semin. Cancer Biol. 26: 52-59.
49. Lebbink, R. J., M. Lowe, T. Chan, H. Khine, X. Wang, and M. T. McManus. 2011. Polymerase II promoter strength determines efficacy of microRNA adapted shRNAs. PLoS One 6: E26213.
50. Hooykaas, M. J., E. Kruse, E. J.Wiertz, and R. J. Lebbink. 2016. Comprehensive profiling of functional Epstein-Barr virus miRNA expression in human cell lines. BMC Genomics 17: 644.
51. van deWeijer, M. L., M. C. Bassik, R. D. Luteijn, C. M. Voorburg, M. A. Lohuis, E. Kremmer, R. C. Hoeben, E. M. LeProust, S. Chen, H. Hoelen, et al. 2014. A high-coverage shRNA screen identifies TMEM129 as an E3 ligase involved in ER-associated protein degradation. Nat. Commun. 5: 3832.
52. Chodosh, J., V. P. Holder, Y. J. Gan, A. Belgaumi, J. Sample, and J. W. Sixbey. 1998. Eradication of latent Epstein-Barr virus by hydroxyurea alters the growthtransformed cell phenotype. J. Infect. Dis. 177: 1194-1201.
53. van Wageningen, S., P. Kemmeren, P. Lijnzaad, T. Margaritis, J. J. Benschop, I. J. de Castro, D. van Leenen, M. J. Groot Koerkamp, C. W. Ko, A. J. Miles, et al. 2010. Functional overlap and regulatory links shape genetic interactions between signaling pathways. Cell 143: 991-1004.
54. Yang, Y. H., S. Dudoit, P. Luu, D. M. Lin, V. Peng, J. Ngai, and T. P. Speed. 2002. Normalization for cDNA microarray data: A robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30: E15.
55. Margaritis, T., P. Lijnzaad, D. van Leenen, D. Bouwmeester, P. Kemmeren, S. R. van Hooff, and F. C. Holstege. 2009. Adaptable gene-specific dye bias correction for two-channel DNA microarrays. Mol. Syst. Biol. 5: 266.
56. Wu, H., M. K. Kerr, X. Cui, and G. A. Churchill. 2003. MAANOVA: A software package for the analysis of spotted cDNA microarray experiments. In The Analysis of Gene Expression Data: Methods and Software. G. Paramigiani, E. S. Garret, R. A. Irizarry, and S. L. Zeger, eds. Springer Verlag New York, New York, p. 313-341.
57. Edgar, R., M. Domrachev, and A. E. Lash. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30: 207-210.
58. Haraguchi, T., Y. Ozaki, and H. Iba. 2009. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res. 37: E43.
59. Baek, D., J. Villén, C. Shin, F. D. Camargo, S. P. Gygi, and D. P. Bartel. 2008. The impact of microRNAs on protein output. Nature 455: 64-71.
60. Selbach, M., B. Schwanhäusser, N. Thierfelder, Z. Fang, R. Khanin, and N. Rajewsky. 2008. Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
61. Kanehisa, M., S. Goto, Y. Sato, M. Furumichi, and M. Tanabe. 2012. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 40: D109-D114.
62. Croft, D., A. F. Mundo, R. Haw, M. Milacic, J. Weiser, G. Wu, M. Caudy, P. Garapati, M. Gillespie, M. R. Kamdar, et al. 2014. The Reactome pathway knowledgebase. Nucleic Acids Res. 42: D472-D477.
63. Paulson, M., C. Press, E. Smith, N. Tanese, and D. E. Levy. 2002. IFNstimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff. Nat. Cell Biol. 4: 140-147.
64. Krämer, O. H., and T. Heinzel. 2010. Phosphorylation-acetylation switch in the regulation of STAT1 signaling. Mol. Cell. Endocrinol. 315: 40-48.
65. Samanta, M., D. Iwakiri, T. Kanda, T. Imaizumi, and K. Takada. 2006. EB virusencoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J. 25: 4207-4214.
66. Lotz, M., C. D. Tsoukas, S. Fong, D. A. Carson, and J. H. Vaughan. 1985. Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma. Eur. J. Immunol. 15: 520-525.
67. Thorley-Lawson, D. A. 1981. The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: The early suppression by T cells of Epstein Barr infection is mediated by interferon. J. Immunol. 126: 829-833.
68. Aman, P., and A. von Gabain. 1990. An Epstein-Barr virus immortalization associated gene segment interferes specifically with the IFN-induced antiproliferative response in human B-lymphoid cell lines. EMBO J. 9: 147-152.
69. Bhattacharya, S., R. Eckner, S. Grossman, E. Oldread, Z. Arany, A. D'Andrea, and D. M. Livingston. 1996. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature 383: 344-347.
70. Zhang, J. J., U. Vinkemeier, W. Gu, D. Chakravarti, C. M. Horvath, and J. E. Darnell, Jr. 1996. Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling. Proc. Natl. Acad. Sci. USA 93: 15092-15096.
71. Tang, X., J. S. Gao, Y. J. Guan, K. E. McLane, Z. L. Yuan, B. Ramratnam, and Y. E. Chin. 2007. Acetylation-dependent signal transduction for type I interferon receptor. Cell 131: 93-105.
72. Gottwein, E., D. L. Corcoran, N. Mukherjee, R. L. Skalsky, M. Hafner, J. D. Nusbaum, P. Shamulailatpam, C. L. Love, S. S. Dave, T. Tuschl, et al. 2011. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10: 515-526.
73. Callegari, S., S. Gastaldello, O. R. Faridani, and M. G. Masucci. 2014. Epstein- Barr virus encoded microRNAs target SUMO-regulated cellular functions. FEBS J. 281: 4935-4950.
74. Wang, F. 2013. Nonhuman primate models for Epstein-Barr virus infection. Curr. Opin. Virol. 3: 233-237.
75. Riley, K. J., G. S. Rabinowitz, and J. A. Steitz. 2010. Comprehensive analysis of rhesus lymphocryptovirus microRNA expression. J. Virol. 84: 5148-5157.
76. Walz, N., T. Christalla, U. Tessmer, and A. Grundhoff. 2010. A global analysis of evolutionary conservation among known and predicted gammaherpesvirus microRNAs. J. Virol. 84: 716-728.
77. Xing, J., L. Ni, S. Wang, K. Wang, R. Lin, and C. Zheng. 2013. Herpes simplex virus 1-encoded tegument protein VP16 abrogates the production of beta inter- feron (IFN) by inhibiting NF-kB activation and blocking IFN regulatory factor 3 to recruit its coactivator CBP. J. Virol. 87: 9788-9801.
78. Lin, R., P. Genin, Y. Mamane, M. Sgarbanti, A. Battistini, W. J. Harrington, Jr., G. N. Barber, and J. Hiscott. 2001. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene 20: 800-811.
79. Lagos, D., G. Pollara, S. Henderson, F. Gratrix, M. Fabani, R. S. Milne, F. Gotch, and C. Boshoff. 2010. miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat. Cell Biol. 12: 513-519.
80. Kincaid, R. P., J. M. Burke, J. C. Cox, E. M. de Villiers, and C. S. Sullivan. 2013. A human torque teno virus encodes a microRNA that inhibits interferon signaling. PLoS Pathog. 9: E1003818.
81. Kang, D., R. L. Skalsky, and B. R. Cullen. 2015. EBV BART microRNAs target multiple pro-apoptotic cellular genes to promote epithelial cell survival. PLoS Pathog. 11: E1004979.
82. Vo, N., and R. H. Goodman. 2001. CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 276: 13505-13508.
83. Yoneyama, M., W. Suhara, Y. Fukuhara, M. Fukuda, E. Nishida, and T. Fujita. 1998. Direct triggering of the type I interferon system by virus infection: Activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17: 1087-1095.
84. Merika, M., A. J. Williams, G. Chen, T. Collins, and D. Thanos. 1998. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol. Cell 1: 277-287.